Basal cell carcinoma

As the most common human cancer worldwide and continuing to increase in incidence, basal cell carcinoma is associated with significant morbidity and cost. Continued advances in research have refined both our insight and approach to this seemingly ubiquitous disease. This 2-part continuing medical education article will provide a comprehensive and contemporary review of basal cell carcinoma. The first article in this series describes our current understanding of this disease regarding epidemiology, cost, clinical and histopathologic presentations, carcinogenesis, natural history, and disease associations. As the most common human cancer worldwide and continuing to increase in incidence, basal cell carcinoma is associated with significant morbidity and cost. Continued advances in research have refined both our insight and approach to this seemingly ubiquitous disease. This 2-part continuing medical education article will provide a comprehensive and contemporary review of basal cell carcinoma. The first article in this series describes our current understanding of this disease regarding epidemiology, cost, clinical and histopathologic presentations, carcinogenesis, natural history, and disease associations. Journal Based CME Instructions and InformationJournal of the American Academy of DermatologyVol. 80Issue 2Preview Full-Text PDF CorrectionJournal of the American Academy of DermatologyVol. 85Issue 2PreviewCameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 2019;80(2):303-317. Full-Text PDF Basal cell carcinoma: Additional subtypes and therapeutic advancesJournal of the American Academy of DermatologyVol. 81Issue 1PreviewTo the Editor: Cameron et al provided a superlative comprehensive review of basal cell carcinoma (BCC).1,2 In addition to summarizing most of the clinical and histologic subtypes of BCC, they also introduced some of the systemic therapies for this tumor. For completeness, less common—but equally important—clinical and histologic subtypes of BCC, as well as recent advances in the management of advanced and metastatic tumors, are presented in this report. Full-Text PDF CME examinationJournal of the American Academy of DermatologyVol. 80Issue 2Preview Full-Text PDF